Advisor Group’s Agios Pharmaceuticals AGIO Stock Holding History

Advisor Group’s Portfolio AGIO Stock Details AGIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	$59K	Buy	1,244 +1,053	+551%	+$39.8K	﹤0.01%	3309
2019 Q3	$6K	Sell	191 -600	-76%	-$24.8K	﹤0.01%	4556
2019 Q2	$39K	Sell	791 -404	-34%	-$21.6K	﹤0.01%	3536
2019 Q1	$80K	Hold	1,195	–	–	﹤0.01%	3040
2018 Q4	$55K	Buy	1,195 +297	+33%	+$18.3K	﹤0.01%	3110
2018 Q3	$69K	Buy	898 +6	+0.7%	+$483	﹤0.01%	3040
2018 Q2	$75K	Hold	892	–	–	﹤0.01%	2758
2018 Q1	$73K	Buy	892 +592	+197%	+$45.8K	﹤0.01%	2794
2017 Q4	$17K	Buy	+300	New	+$18.9K	﹤0.01%	3792
2016 Q3	–	Sell	-323	Closed	-$13K	–	4455
2016 Q2	$13K	Buy	+323	New	+$16K	﹤0.01%	3318

Other funds holding AGIO

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Advisor Group's AGIO Position: Q4 2019 in Review

Advisor Group increased its Agios Pharmaceuticals (AGIO) stake by 551% in Q4 2019, buying an estimated $39.8K and bringing the position to 1,244 shares worth $59K. The position accounts for ﹤0.01% of the portfolio, ranked #3309.

Advisor Group first reported a position in AGIO in Q2 2016 and has held it in 10 quarters since. The position peaked at $80K in Q1 2019. 199 funds tracked by Wall St. Rank hold AGIO as of Q4 2019.

Advisor Group held 1,244 shares of Agios Pharmaceuticals worth $59K as of Q4 2019.
Advisor Group bought 1,053 Agios Pharmaceuticals shares in Q4 2019, an estimated $39.8K.
Agios Pharmaceuticals made up ﹤0.01% of Advisor Group's portfolio in Q4 2019, its #3309 holding.
Advisor Group first reported a position in Agios Pharmaceuticals in Q2 2016 and has held it in 10 quarters since.
Advisor Group's Agios Pharmaceuticals position peaked at $80K in Q1 2019.
199 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.